2013 Form 10-K Financial Statement
#000114420414012277 Filed on February 28, 2014
Income Statement
| Concept | 2013 | 2012 Q4 | 2012 |
|---|---|---|---|
| Revenue | $30.08M | $1.968M | $20.37M |
| YoY Change | 47.67% | 1620.31% | 4581.27% |
| Cost Of Revenue | $9.974M | $9.167M | |
| YoY Change | 8.8% | 9067.0% | |
| Gross Profit | $20.11M | $11.20M | |
| YoY Change | 79.47% | 2701.0% | |
| Gross Profit Margin | 66.84% | 55.0% | |
| Selling, General & Admin | $16.39M | $4.190M | $9.521M |
| YoY Change | 72.12% | 143.6% | 36.01% |
| % of Gross Profit | 81.5% | 84.98% | |
| Research & Development | $1.712M | $2.515M | $1.158M |
| YoY Change | 47.84% | -62.48% | -97.38% |
| % of Gross Profit | 8.51% | 10.34% | |
| Depreciation & Amortization | $1.110M | $480.0K | $567.0K |
| YoY Change | 95.77% | 1500.0% | 282.49% |
| % of Gross Profit | 5.52% | 5.06% | |
| Operating Expenses | $18.10M | $2.515M | $10.68M |
| YoY Change | 69.49% | -62.48% | -75.83% |
| Operating Profit | $898.0K | -$3.635M | -$42.00K |
| YoY Change | -2238.1% | -56.42% | -99.9% |
| Interest Expense | $467.0K | $1.327M | |
| YoY Change | -64.81% | 94.7% | |
| % of Operating Profit | 52.0% | ||
| Other Income/Expense, Net | -$305.0K | -$241.0K | |
| YoY Change | 26.56% | ||
| Pretax Income | $126.0K | $22.24M | -$1.610M |
| YoY Change | -107.83% | -434.44% | -96.88% |
| Income Tax | $20.00K | $90.00K | -$36.00K |
| % Of Pretax Income | 15.87% | 0.4% | |
| Net Earnings | $301.0K | $22.22M | -$1.506M |
| YoY Change | -119.99% | -434.14% | -97.08% |
| Net Earnings / Revenue | 1.0% | 1129.31% | -7.39% |
| Basic Earnings Per Share | -$0.92 | -$1.27 | |
| Diluted Earnings Per Share | -$0.92 | -$1.27 | |
| COMMON SHARES | |||
| Basic Shares Outstanding | 5.071K shares | 21.76M shares | |
| Diluted Shares Outstanding | 5.071K shares | 21.76M shares |
Balance Sheet
| Concept | 2013 | 2012 Q4 | 2012 |
|---|---|---|---|
| SHORT-TERM ASSETS | |||
| Cash & Short-Term Investments | $11.10M | $0.00 | $0.00 |
| YoY Change | -100.0% | -100.0% | |
| Cash & Equivalents | $11.10M | $11.00K | $0.00 |
| Short-Term Investments | |||
| Other Short-Term Assets | $600.0K | $300.0K | $300.0K |
| YoY Change | 100.0% | -62.5% | -62.5% |
| Inventory | $3.500M | $2.810M | $2.800M |
| Prepaid Expenses | $313.0K | ||
| Receivables | $12.50M | $5.432M | $5.400M |
| Other Receivables | $0.00 | $0.00 | $0.00 |
| Total Short-Term Assets | $27.70M | $8.566M | $8.600M |
| YoY Change | 222.09% | -85.24% | -85.17% |
| LONG-TERM ASSETS | |||
| Property, Plant & Equipment | $4.500M | $4.880M | $4.900M |
| YoY Change | -8.16% | 466.54% | 444.44% |
| Goodwill | $0.00 | ||
| YoY Change | |||
| Intangibles | $85.00K | ||
| YoY Change | |||
| Long-Term Investments | |||
| YoY Change | |||
| Other Assets | $0.00 | $302.3K | $200.0K |
| YoY Change | -100.0% | 202.29% | 100.0% |
| Total Long-Term Assets | $16.80M | $5.182M | $5.100M |
| YoY Change | 229.41% | 19.03% | 15.91% |
| TOTAL ASSETS | |||
| Total Short-Term Assets | $27.70M | $8.566M | $8.600M |
| Total Long-Term Assets | $16.80M | $5.182M | $5.100M |
| Total Assets | $44.50M | $13.75M | $13.70M |
| YoY Change | 224.82% | -77.96% | -78.04% |
| SHORT-TERM LIABILITIES | |||
| YoY Change | |||
| Accounts Payable | $1.400M | $1.994M | $2.000M |
| YoY Change | -30.0% | -36.71% | -37.5% |
| Accrued Expenses | $1.400M | $927.0K | $900.0K |
| YoY Change | 55.56% | -77.39% | -78.05% |
| Deferred Revenue | |||
| YoY Change | |||
| Short-Term Debt | $0.00 | $4.100M | $4.100M |
| YoY Change | -100.0% | ||
| Long-Term Debt Due | |||
| YoY Change | |||
| Total Short-Term Liabilities | $3.500M | $7.712M | $7.700M |
| YoY Change | -54.55% | 6.7% | 6.94% |
| LONG-TERM LIABILITIES | |||
| Long-Term Debt | $0.00 | $48.80M | $48.80M |
| YoY Change | -100.0% | 182.08% | 182.08% |
| Other Long-Term Liabilities | |||
| YoY Change | |||
| Total Long-Term Liabilities | $0.00 | $48.80M | $48.80M |
| YoY Change | -100.0% | 182.08% | 182.08% |
| TOTAL LIABILITIES | |||
| Total Short-Term Liabilities | $3.500M | $7.712M | $7.700M |
| Total Long-Term Liabilities | $0.00 | $48.80M | $48.80M |
| Total Liabilities | $3.500M | $10.59M | $56.50M |
| YoY Change | -93.81% | -56.87% | 129.67% |
| SHAREHOLDERS EQUITY | |||
| Retained Earnings | -$43.80M | ||
| YoY Change | -79.84% | ||
| Common Stock | |||
| YoY Change | |||
| Preferred Stock | |||
| YoY Change | |||
| Treasury Stock (at cost) | $0.00 | ||
| YoY Change | |||
| Treasury Stock Shares | |||
| Shareholders Equity | $41.00M | -$42.72M | -$42.70M |
| YoY Change | |||
| Total Liabilities & Shareholders Equity | $44.50M | $13.75M | $13.70M |
| YoY Change | 224.82% | -77.96% | -78.04% |
Cashflow Statement
| Concept | 2013 | 2012 Q4 | 2012 |
|---|---|---|---|
| OPERATING ACTIVITIES | |||
| Net Income | $301.0K | $22.22M | -$1.506M |
| YoY Change | -119.99% | -434.14% | -97.08% |
| Depreciation, Depletion And Amortization | $1.110M | $480.0K | $567.0K |
| YoY Change | 95.77% | 1500.0% | 282.49% |
| Cash From Operating Activities | -$5.484M | $21.98M | -$137.0K |
| YoY Change | 3902.92% | -301.1% | -99.71% |
| INVESTING ACTIVITIES | |||
| Capital Expenditures | $191.0K | $240.0K | $292.0K |
| YoY Change | -34.59% | -442.86% | -59.44% |
| Acquisitions | |||
| YoY Change | |||
| Other Investing Activities | $20.46M | $10.00K | $0.00 |
| YoY Change | |||
| Cash From Investing Activities | $20.27M | $250.0K | -$290.0K |
| YoY Change | -7089.66% | -457.14% | -59.72% |
| FINANCING ACTIVITIES | |||
| Cash Dividend Paid | |||
| YoY Change | |||
| Common Stock Issuance & Retirement, Net | $433.0K | -$3.261M | |
| YoY Change | -113.28% | -113.66% | |
| Debt Paid & Issued, Net | |||
| YoY Change | |||
| Cash From Financing Activities | -$3.689M | -3.040M | $440.0K |
| YoY Change | -938.41% | 120.29% | -99.35% |
| NET CHANGE | |||
| Cash From Operating Activities | -$5.484M | 21.98M | -$137.0K |
| Cash From Investing Activities | 20.27M | 250.0K | -290.0K |
| Cash From Financing Activities | -$3.689M | -3.040M | $440.0K |
| Net Change In Cash | -$9.173M | 19.19M | $303.0K |
| YoY Change | -3127.39% | -255.01% | -98.41% |
| FREE CASH FLOW | |||
| Cash From Operating Activities | -$5.484M | $21.98M | -$137.0K |
| Capital Expenditures | $191.0K | $240.0K | $292.0K |
| Free Cash Flow | -$5.675M | $21.74M | -$429.0K |
| YoY Change | 1222.84% | -300.18% | -99.12% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2013 | us-gaap |
Nature Of Operations
NatureOfOperations
|
<div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="left"><strong><font style="FONT-FAMILY: Times; FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">  </font> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Organization and Business</font></strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 22.5pt" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times">  </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 22.5pt" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times">  </font> <font style="FONT-SIZE: 10pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">ANI Pharmaceuticals, Inc. and its consolidated subsidiary, ANIP Acquisition Company (together, the “Company”) is a specialty pharmaceutical company, developing and marketing generic and branded prescription products. The</font> <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">Company was organized as a Delaware corporation in April 2001.</font> <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">At its two facilities located in Baudette, Minnesota, which have a combined manufacturing, packaging and laboratory capacity totaling 173,000 square feet, the Company manufactures oral solid dose products, as well as liquids and topicals, including those that must be manufactured in a fully contained environment due to their potency. The Company also performs contract manufacturing for other pharmaceutical companies.</font></font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 22.5pt" align="left"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 22.5pt" align="left"><font style="FONT-SIZE: 10pt">On June 19, 2013, BioSante Pharmaceuticals, Inc. (“BioSante”) acquired ANIP Acquisition Company (“ANIP”) in an all-stock, tax-free reorganization (the “Merger”) (Note 2), in which ANIP became a wholly-owned subsidiary of BioSante. BioSante was renamed ANI Pharmaceuticals, Inc. The Merger was accounted for as a reverse acquisition pursuant to which ANIP was considered the acquiring entity for accounting purposes. As such, ANIP's historical results of operations replace BioSante's historical results of operations for all periods prior to the Merger. The results of operations of both companies are included in the Company’s consolidated financial statements for all periods after completion of the Merger.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 22.5pt" align="left"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 22.5pt" align="left"><font style="FONT-SIZE: 10pt">The Company's operations are subject to certain risks and uncertainties including, among others, current and potential competitors with greater resources, dependence on significant customers, lack of operating history and uncertainty of future profitability and possible fluctuations in financial results. The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates continuity of operations, realization of assets, and satisfaction of liabilities in the ordinary course of business. The propriety of using the going-concern basis is dependent upon, among other things, the achievement of future profitable operations, the ability to generate sufficient cash from operations, and potential other funding sources, including cash on hand, to meet the Company’s obligations as they become due. Management believes the going-concern basis is appropriate for the accompanying consolidated financial statements based on its current operating plan through December 31, 2014.</font></div> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> | |
| CY2013 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="left"><strong><font style="FONT-FAMILY: Times; FONT-SIZE: 10pt">Use of Estimates</font></strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 0.25in" align="left"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 0.25in" align="left"><font style="FONT-SIZE: 10pt">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. In the accompanying consolidated financial statements, estimates are used for, but not limited to, stock-based compensation, allowance for doubtful accounts, accruals for chargebacks, returns and other allowances, allowance for inventory obsolescence, valuation of derivative liabilities, accruals for contingent liabilities, fair value of long-lived assets, deferred taxes and valuation allowance, and the depreciable lives of fixed assets. Actual results could differ from those estimates.</font></div> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> | |
| CY2013 | us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="left"><strong><font style="FONT-FAMILY: Times; FONT-SIZE: 10pt">Credit Concentration</font></strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 0.25in" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times">  </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 0.25in" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">The Company's customers are primarily wholesale distributors, chain drug stores, group purchasing organizations, and other pharmaceutical companies.</font></font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 0.25in" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times">  </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 0.25in" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times"> During the year ended December 31, 2013, three customers represented approximately <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 27</font>%, <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 18</font>%, and <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 10</font>% of net revenues, respectively. As of December 31, 2013, accounts receivable from these customers totaled <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 68</font>% of net accounts receivable. During the year ended December 31, 2012, three customers represented approximately <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 25</font>%, <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 21</font>%, and <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 11</font>% of net revenues, respectively.</font></div> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> | |
| CY2013Q2 | anip |
Business Combination Purchase Price Allocation Restricted Cash
BusinessCombinationPurchasePriceAllocationRestrictedCash
|
2260000 | USD |
| CY2013Q2 | anip |
Business Combination Purchase Price Allocation Intangible Assets
BusinessCombinationPurchasePriceAllocationIntangibleAssets
|
10900000 | USD |
| CY2013Q2 | anip |
Business Combination Purchase Price Allocation Other Assets
BusinessCombinationPurchasePriceAllocationOtherAssets
|
79000 | USD |
| CY2013Q2 | anip |
Business Combination Purchase Price Allocation Deferred Tax Assets Net
BusinessCombinationPurchasePriceAllocationDeferredTaxAssetsNet
|
0 | USD |
| CY2013Q2 | anip |
Business Combination Purchase Price Allocation Goodwill
BusinessCombinationPurchasePriceAllocationGoodwill
|
1838000 | USD |
| CY2013Q2 | anip |
Business Combination Purchase Price Allocation Assets Total
BusinessCombinationPurchasePriceAllocationAssetsTotal
|
33275000 | USD |
| CY2013Q2 | anip |
Business Combination Purchase Price Allocation Accrued Severance
BusinessCombinationPurchasePriceAllocationAccruedSeverance
|
2965000 | USD |
| CY2013Q2 | anip |
Business Combination Purchase Price Allocation Other Liabilities
BusinessCombinationPurchasePriceAllocationOtherLiabilities
|
515000 | USD |
| CY2013Q2 | anip |
Business Combination Purchase Price Allocation Liabilities Total
BusinessCombinationPurchasePriceAllocationLiabilitiesTotal
|
3480000 | USD |
| CY2012 | us-gaap |
Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
|
22671000 | USD |
| CY2013 | us-gaap |
Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
|
30228000 | USD |
| CY2012 | us-gaap |
Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
|
-27718000 | USD |
| CY2013 | us-gaap |
Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
|
89000 | USD |
| CY2013Q2 | us-gaap |
Share Price
SharePrice
|
1.22 | |
| CY2012Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
11000 | USD |
| CY2012 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
2700000 | shares |
| CY2013 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
2700000 | shares |
| CY2013 | us-gaap |
Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
|
one-for-six | |
| CY2013Q4 | anip |
Fdic Guaranteed Amount
FdicGuaranteedAmount
|
250000 | USD |
| CY2013Q4 | anip |
Business Acquisition Cost Of Acquired Entity Transaction Costs Legal Fee
BusinessAcquisitionCostOfAcquiredEntityTransactionCostsLegalFee
|
1227000 | USD |
| CY2013Q4 | anip |
Business Acquisition Cost Of Acquired Entity Transaction Costs Accounting Fees
BusinessAcquisitionCostOfAcquiredEntityTransactionCostsAccountingFees
|
122000 | USD |
| CY2013Q4 | anip |
Business Acquisition Cost Of Acquired Entity Transaction Costs Consulting Fees
BusinessAcquisitionCostOfAcquiredEntityTransactionCostsConsultingFees
|
119000 | USD |
| CY2013Q4 | anip |
Business Acquisition Cost Of Acquired Entity Transaction Costs Monitory And Advisory Fees
BusinessAcquisitionCostOfAcquiredEntityTransactionCostsMonitoryAndAdvisoryFees
|
390000 | USD |
| CY2013Q4 | anip |
Business Acquisition Cost Of Acquired Entity Transaction Costs Transaction Bonuses
BusinessAcquisitionCostOfAcquiredEntityTransactionCostsTransactionBonuses
|
4801000 | USD |
| CY2013Q4 | anip |
Business Acquisition Cost Of Acquired Entity Transaction Costs Other Expenses
BusinessAcquisitionCostOfAcquiredEntityTransactionCostsOtherExpenses
|
429000 | USD |
| CY2013Q4 | us-gaap |
Business Acquisition Cost Of Acquired Entity Transaction Costs
BusinessAcquisitionCostOfAcquiredEntityTransactionCosts
|
7088000 | USD |
| CY2013Q2 | anip |
Business Combination Cost Of Acquired Entity Purchase Price
BusinessCombinationCostOfAcquiredEntityPurchasePrice
|
29795000 | USD |
| CY2013Q2 | anip |
Business Combination Purchase Price Allocation Cash And Cash Equivalents
BusinessCombinationPurchasePriceAllocationCashAndCashEquivalents
|
18198000 | USD |
| CY2013Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
11105000 | USD |
| CY2012Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
5432000 | USD |
| CY2013Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
12513000 | USD |
| CY2012Q4 | us-gaap |
Inventory Net
InventoryNet
|
2810000 | USD |
| CY2013Q4 | us-gaap |
Inventory Net
InventoryNet
|
3518000 | USD |
| CY2012Q4 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
313000 | USD |
| CY2013Q4 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
580000 | USD |
| CY2012Q4 | us-gaap |
Assets Current
AssetsCurrent
|
8566000 | USD |
| CY2013Q4 | us-gaap |
Assets Current
AssetsCurrent
|
27716000 | USD |
| CY2012Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
4880000 | USD |
| CY2013Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
4537000 | USD |
| CY2012Q4 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
85000 | USD |
| CY2013Q4 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
10409000 | USD |
| CY2012Q4 | us-gaap |
Goodwill
Goodwill
|
0 | USD |
| CY2013Q4 | us-gaap |
Goodwill
Goodwill
|
1838000 | USD |
| CY2012Q4 | us-gaap |
Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
|
217000 | USD |
| CY2013Q4 | us-gaap |
Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
|
0 | USD |
| CY2012Q4 | us-gaap |
Assets
Assets
|
13748000 | USD |
| CY2013Q4 | us-gaap |
Assets
Assets
|
44500000 | USD |
| CY2012Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
1994000 | USD |
| CY2013Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
1429000 | USD |
| CY2012Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
927000 | USD |
| CY2013Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
1326000 | USD |
| CY2013Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-48472000 | USD |
| CY2013Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
3538000 | USD |
| CY2012Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
| CY2013Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
| CY2012Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
1083000 | USD |
| CY2013Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
89501000 | USD |
| CY2012Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-43798000 | USD |
| CY2012Q4 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
75000 | USD |
| CY2013Q4 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
651000 | USD |
| CY2013Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
|
991000 | USD |
| CY2012Q4 | anip |
Returned Goods Reserve
ReturnedGoodsReserve
|
411000 | USD |
| CY2013Q4 | anip |
Returned Goods Reserve
ReturnedGoodsReserve
|
736000 | USD |
| CY2012Q4 | us-gaap |
Deferred Revenue
DeferredRevenue
|
315000 | USD |
| CY2013Q4 | us-gaap |
Deferred Revenue
DeferredRevenue
|
47000 | USD |
| CY2012Q4 | us-gaap |
Line Of Credit Facility Amount Outstanding
LineOfCreditFacilityAmountOutstanding
|
4065000 | USD |
| CY2013Q4 | us-gaap |
Line Of Credit Facility Amount Outstanding
LineOfCreditFacilityAmountOutstanding
|
0 | USD |
| CY2012Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
7712000 | USD |
| CY2012Q4 | us-gaap |
Treasury Stock Value
TreasuryStockValue
|
0 | USD |
| CY2013Q4 | us-gaap |
Treasury Stock Value
TreasuryStockValue
|
68000 | USD |
| CY2012Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-42715000 | USD |
| CY2013Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
40962000 | USD |
| CY2012Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
13748000 | USD |
| CY2013Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
44500000 | USD |
| CY2012Q4 | us-gaap |
Inventory Raw Materials
InventoryRawMaterials
|
975000 | USD |
| CY2013Q4 | us-gaap |
Inventory Raw Materials
InventoryRawMaterials
|
1480000 | USD |
| CY2012Q4 | us-gaap |
Retail Related Inventory Packaging And Other Supplies
RetailRelatedInventoryPackagingAndOtherSupplies
|
585000 | USD |
| CY2013Q4 | us-gaap |
Retail Related Inventory Packaging And Other Supplies
RetailRelatedInventoryPackagingAndOtherSupplies
|
766000 | USD |
| CY2012Q4 | us-gaap |
Inventory Work In Process
InventoryWorkInProcess
|
374000 | USD |
| CY2013Q4 | us-gaap |
Inventory Work In Process
InventoryWorkInProcess
|
162000 | USD |
| CY2012Q4 | us-gaap |
Inventory Finished Goods
InventoryFinishedGoods
|
891000 | USD |
| CY2013Q4 | us-gaap |
Inventory Finished Goods
InventoryFinishedGoods
|
1152000 | USD |
| CY2012Q4 | us-gaap |
Inventory Gross
InventoryGross
|
2825000 | USD |
| CY2013Q4 | us-gaap |
Inventory Gross
InventoryGross
|
3560000 | USD |
| CY2012Q4 | us-gaap |
Inventory Valuation Reserves
InventoryValuationReserves
|
15000 | USD |
| CY2013Q4 | us-gaap |
Inventory Valuation Reserves
InventoryValuationReserves
|
42000 | USD |
| CY2012Q4 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
160000 | USD |
| CY2013Q4 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
11060000 | USD |
| CY2013Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
|
991000 | USD |
| CY2013Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
|
991000 | USD |
| CY2013Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
|
5449000 | USD |
| CY2013Q4 | anip |
Finite Lived Intangible Assets Amortization Expense Total
FiniteLivedIntangibleAssetsAmortizationExpenseTotal
|
10409000 | USD |
| CY2012 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
50000 | USD |
| CY2013 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
600000 | USD |
| CY2013 | us-gaap |
Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
|
1800000 | USD |
| CY2012Q4 | us-gaap |
Liabilities Of Disposal Group Including Discontinued Operation
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation
|
400000 | USD |
| CY2013Q4 | us-gaap |
Liabilities Of Disposal Group Including Discontinued Operation
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation
|
200000 | USD |
| CY2012 | us-gaap |
Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax
DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax
|
68000 | USD |
| CY2013 | us-gaap |
Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax
DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax
|
195000 | USD |
| CY2012 | us-gaap |
Discontinued Operation Tax Effect Of Income Loss From Disposal Of Discontinued Operation
DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation
|
36000 | USD |
| CY2013 | us-gaap |
Discontinued Operation Tax Effect Of Income Loss From Disposal Of Discontinued Operation
DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation
|
38000 | USD |
| CY2012Q2 | us-gaap |
Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
|
5000000 | USD |
| CY2011Q4 | us-gaap |
Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
|
3500000 | USD |
| CY2012Q4 | us-gaap |
Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
|
6000000 | USD |
| CY2012 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-42000 | USD |
| CY2013 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-305000 | USD |
| CY2012 | us-gaap |
Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
|
-1574000 | USD |
| CY2013 | us-gaap |
Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
|
4975000 | USD |
| CY2012 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-8496000 | USD |
| CY2012Q2 | us-gaap |
Line Of Credit Facility Interest Rate Description
LineOfCreditFacilityInterestRateDescription
|
The revolver loan agreement bore interest daily at the greater of (i) LIBOR plus 5%, or (ii) 6%, and was secured by substantially all of the Companys assets. | |
| CY2011Q4 | us-gaap |
Line Of Credit Facility Interest Rate Description
LineOfCreditFacilityInterestRateDescription
|
Base Rate, as defined, plus 6.0% | |
| CY2012Q2 | us-gaap |
Line Of Credit Facility Unused Capacity Commitment Fee Percentage
LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
|
0.00375 | pure |
| CY2011Q4 | us-gaap |
Line Of Credit Facility Unused Capacity Commitment Fee Percentage
LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
|
0.0075 | pure |
| CY2012Q2 | anip |
Line Of Credit Facility Management Fee
LineOfCreditFacilityManagementFee
|
18000 | USD |
| CY2011Q4 | anip |
Line Of Credit Facility Management Fee
LineOfCreditFacilityManagementFee
|
9000 | USD |
| CY2012 | us-gaap |
Line Of Credit Facility Covenant Terms
LineOfCreditFacilityCovenantTerms
|
Under the agreement, the Company was required to maintain a minimum fixed charge coverage ratio of 1.1 to 1.0, calculated by dividing (a) (i) earnings before interest, taxes, depreciation and amortization (EBITDA) less (ii) unfinanced capital expenditures, by the sum of cash paid for (b) (i) interest and (ii) monitoring and advisory fees (Note 14). Also, the Company was required to generate at least $0.8 million in EBITDA measured on a trailing four-quarter basis. Restrictive covenants applied to, among other things, research and development expenditures, additional liens, mergers or consolidations, and sales of assets. | |
| CY2013 | us-gaap |
Line Of Credit Facility Covenant Terms
LineOfCreditFacilityCovenantTerms
|
Beginning in 2013, the Company was required to maintain a minimum fixed charge coverage ratio of 1.1 to 1.0. Also beginning in 2013, the Company was required to generate at least 0.2 million in EBITDA during the three month period ending March 31, 2013, $0.5 million in EBITDA during the six month period ending June 30, 2013, $0.7 million in EBITDA during the nine month period ending September 30, 2013, and $0.9 million in EBITDA for the year ended December 31, 2013 and for every quarterly period thereafter measured on a trailing four-quarter basis. Restrictive covenants applied to, among other things, additional liens, mergers or consolidations, and sales of assets. | |
| CY2013 | anip |
Line Of Credit Facility Termination Fee In First Year
LineOfCreditFacilityTerminationFeeInFirstYear
|
200000 | USD |
| CY2013 | anip |
Line Of Credit Facility Termination Fee In Second Year
LineOfCreditFacilityTerminationFeeInSecondYear
|
100000 | USD |
| CY2013 | anip |
Line Of Credit Facility Termination Fee After Second Year
LineOfCreditFacilityTerminationFeeAfterSecondYear
|
60000 | USD |
| CY2012Q4 | us-gaap |
Line Of Credit Facility Interest Rate At Period End
LineOfCreditFacilityInterestRateAtPeriodEnd
|
0.060 | pure |
| CY2012 | us-gaap |
Lease And Rental Expense
LeaseAndRentalExpense
|
18000 | USD |
| CY2013 | us-gaap |
Lease And Rental Expense
LeaseAndRentalExpense
|
36000 | USD |
| CY2013 | anip |
Monitoring And Advisory Fee In Conjunction With Business Combination
MonitoringAndAdvisoryFeeInConjunctionWithBusinessCombination
|
400000 | USD |
| CY2012 | anip |
Monitoring And Advisory Fee
MonitoringAndAdvisoryFee
|
200000 | USD |
| CY2013 | anip |
Monitoring And Advisory Fee
MonitoringAndAdvisoryFee
|
500000 | USD |
| CY2013Q4 | us-gaap |
Treasury Stock Shares
TreasuryStockShares
|
9233 | shares |
| CY2013 | us-gaap |
Fair Value Inputs Discount Rate
FairValueInputsDiscountRate
|
0.15 | pure |
| CY2012 | us-gaap |
Revenues
Revenues
|
20371000 | USD |
| CY2013 | us-gaap |
Revenues
Revenues
|
30082000 | USD |
| CY2012 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
9167000 | USD |
| CY2013 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
9974000 | USD |
| CY2012 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
1158000 | USD |
| CY2013 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
1712000 | USD |
| CY2012 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
9521000 | USD |
| CY2013 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
16388000 | USD |
| CY2012 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
567000 | USD |
| CY2013 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
1110000 | USD |
| CY2012 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
20413000 | USD |
| CY2013 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
29184000 | USD |
| CY2013 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
898000 | USD |
| CY2012 | us-gaap |
Interest Expense
InterestExpense
|
1327000 | USD |
| CY2013 | us-gaap |
Interest Expense
InterestExpense
|
467000 | USD |
| CY2012 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-241000 | USD |
| CY2012 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-1610000 | USD |
| CY2013 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
126000 | USD |
| CY2012 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
-36000 | USD |
| CY2013 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
20000 | USD |
| CY2013 | us-gaap |
Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
|
106000 | USD |
| CY2012 | us-gaap |
Discontinued Operation Provision For Loss Gain On Disposal Net Of Tax
DiscontinuedOperationProvisionForLossGainOnDisposalNetOfTax
|
-68000 | USD |
| CY2013 | us-gaap |
Discontinued Operation Provision For Loss Gain On Disposal Net Of Tax
DiscontinuedOperationProvisionForLossGainOnDisposalNetOfTax
|
-195000 | USD |
| CY2012 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1506000 | USD |
| CY2013 | us-gaap |
Net Income Loss
NetIncomeLoss
|
301000 | USD |
| CY2012 | us-gaap |
Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
|
6922000 | USD |
| CY2012 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
327000 | USD |
| CY2013 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
7081000 | USD |
| CY2012 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
702000 | USD |
| CY2013 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
708000 | USD |
| CY2012 | us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
88000 | USD |
| CY2013 | us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
188000 | USD |
| CY2012 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
785000 | USD |
| CY2013 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-565000 | USD |
| CY2012 | us-gaap |
Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
|
205000 | USD |
| CY2013 | us-gaap |
Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
|
25000 | USD |
| CY2013 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-4869000 | USD |
| CY2012 | us-gaap |
Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
|
0 | |
| CY2013 | anip |
Non Cash Compensation Relating To Business Combination
NonCashCompensationRelatingToBusinessCombination
|
4418000 | USD |
| CY2013 | us-gaap |
Cash Acquired In Excess Of Payments To Acquire Business
CashAcquiredInExcessOfPaymentsToAcquireBusiness
|
18198000 | USD |
| CY2012 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
292000 | USD |
| CY2013 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
191000 | USD |
| CY2012 | us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
-292000 | USD |
| CY2013 | us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
20267000 | USD |
| CY2012 | us-gaap |
Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
|
1001000 | USD |
| CY2013 | us-gaap |
Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
|
-4065000 | USD |
| CY2012 | us-gaap |
Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
|
261000 | USD |
| CY2013 | us-gaap |
Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
|
0 | USD |
| CY2012 | us-gaap |
Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
|
0 | USD |
| CY2013 | us-gaap |
Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
|
433000 | USD |
| CY2012 | us-gaap |
Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
|
740000 | USD |
| CY2013 | us-gaap |
Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
|
-3689000 | USD |
| CY2012 | us-gaap |
Net Cash Provided By Used In Discontinued Operations
NetCashProvidedByUsedInDiscontinuedOperations
|
-300000 | USD |
| CY2013 | us-gaap |
Net Cash Provided By Used In Discontinued Operations
NetCashProvidedByUsedInDiscontinuedOperations
|
0 | USD |
| CY2012 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
440000 | USD |
| CY2013 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-3689000 | USD |
| CY2012 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
11000 | USD |
| CY2013 | us-gaap |
Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
|
-0.96 | |
| CY2012 | us-gaap |
Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare
|
0 | |
| CY2013 | us-gaap |
Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare
|
0.04 | |
| CY2012 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
0 | |
| CY2013 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.92 | |
| CY2012 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
0 | shares |
| CY2013 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
5071000 | shares |
| CY2012 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
0 | USD |
| CY2013 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
36000 | USD |
| CY2012 | us-gaap |
Other Noncash Income Expense
OtherNoncashIncomeExpense
|
-1071000 | USD |
| CY2013 | us-gaap |
Other Noncash Income Expense
OtherNoncashIncomeExpense
|
-217000 | USD |
| CY2012 | anip |
Non Cash Compensation Relating To Business Combination
NonCashCompensationRelatingToBusinessCombination
|
0 | USD |
| CY2012 | us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
5000 | USD |
| CY2013 | us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
-5289000 | USD |
| CY2012 | us-gaap |
Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
|
-142000 | USD |
| CY2013 | us-gaap |
Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
|
-195000 | USD |
| CY2012 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-137000 | USD |
| CY2013 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-5484000 | USD |
| CY2012 | us-gaap |
Cash Acquired In Excess Of Payments To Acquire Business
CashAcquiredInExcessOfPaymentsToAcquireBusiness
|
0 | USD |
| CY2013 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
11094000 | USD |
| CY2011Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
0 | USD |
| CY2012 | us-gaap |
Interest Paid
InterestPaid
|
255000 | USD |
| CY2013 | us-gaap |
Interest Paid
InterestPaid
|
250000 | USD |
| CY2012 | us-gaap |
Stock Issued1
StockIssued1
|
0 | USD |
| CY2013 | us-gaap |
Stock Issued1
StockIssued1
|
40034000 | USD |
| CY2012 | anip |
Cancellation Of Redeemable Convertible Preferred And Common Stock Value
CancellationOfRedeemableConvertiblePreferredAndCommonStockValue
|
0 | USD |
| CY2013 | anip |
Cancellation Of Redeemable Convertible Preferred And Common Stock Value
CancellationOfRedeemableConvertiblePreferredAndCommonStockValue
|
53726000 | USD |
| CY2012 | us-gaap |
Dividends Preferred Stock
DividendsPreferredStock
|
6922000 | USD |
| CY2013 | us-gaap |
Dividends Preferred Stock
DividendsPreferredStock
|
4975000 | USD |
| CY2012 | anip |
Stock Issued During Period Value Cashless Warrants Exercise
StockIssuedDuringPeriodValueCashlessWarrantsExercise
|
5000 | USD |
| CY2013 | anip |
Stock Issued During Period Value Cashless Warrants Exercise
StockIssuedDuringPeriodValueCashlessWarrantsExercise
|
0 | USD |
| CY2012 | us-gaap |
Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
|
17610000 | USD |
| CY2013 | us-gaap |
Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
|
0 | USD |
| CY2013 | dei |
Document Type
DocumentType
|
10-K | |
| CY2013 | us-gaap |
Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
|
2.459 | pure |
| CY2012 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
1.007 | pure |
| CY2013 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
-3.004 | pure |
| CY2012 | us-gaap |
Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
|
-0.857 | pure |
| CY2013 | dei |
Amendment Flag
AmendmentFlag
|
false | |
| CY2013 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2013-12-31 | |
| CY2013 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2013 | |
| CY2013 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
FY | |
| CY2013 | dei |
Trading Symbol
TradingSymbol
|
ANIP | |
| CY2013 | dei |
Entity Registrant Name
EntityRegistrantName
|
ANI PHARMACEUTICALS INC | |
| CY2013 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001023024 | |
| CY2013 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | |
| CY2013 | dei |
Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
|
No | |
| CY2013 | dei |
Entity Voluntary Filers
EntityVoluntaryFilers
|
No | |
| CY2013 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
| CY2013 | dei |
Entity Filer Category
EntityFilerCategory
|
Smaller Reporting Company | |
| CY2013Q2 | dei |
Entity Public Float
EntityPublicFloat
|
36800000 | USD |
| CY2012Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
0 | USD |
| CY2013Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
0 | USD |
| CY2012 | us-gaap |
Depreciation
Depreciation
|
517000 | USD |
| CY2013 | us-gaap |
Depreciation
Depreciation
|
534000 | USD |
| CY2012Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
2663000 | USD |
| CY2013Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
3197000 | USD |
| CY2012Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
7543000 | USD |
| CY2013Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
7734000 | USD |
| CY2013Q4 | us-gaap |
Operating Loss Carryforwards
OperatingLossCarryforwards
|
235300000 | USD |
| CY2012Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
| CY2013Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
| CY2012Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
1666667 | shares |
| CY2013Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
1666667 | shares |
| CY2012Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
| CY2013Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
| CY2012Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
| CY2013Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
| CY2013Q4 | anip |
Contingent Consideration Classified As Liability Fair Value Disclosure
ContingentConsiderationClassifiedAsLiabilityFairValueDisclosure
|
0 | USD |
| CY2012Q4 | anip |
Warrants Fair Value Disclosure
WarrantsFairValueDisclosure
|
0 | USD |
| CY2013 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.161 | pure |
| CY2013 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P6Y3M | |
| CY2013 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
|
0.0172 | pure |
| CY2012 | us-gaap |
Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
|
0 | USD |
| CY2013 | us-gaap |
Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
|
20000 | USD |
| CY2012 | us-gaap |
Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
|
0 | USD |
| CY2013 | us-gaap |
Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
|
0 | USD |
| CY2012 | us-gaap |
Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
|
0 | USD |
| CY2013 | us-gaap |
Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
|
20000 | USD |
| CY2012 | us-gaap |
Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
|
-1486000 | USD |
| CY2013 | us-gaap |
Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
|
635000 | USD |
| CY2012 | us-gaap |
Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
|
-35000 | USD |
| CY2013 | us-gaap |
Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
|
-221000 | USD |
| CY2012 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
-1522000 | USD |
| CY2013 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
414000 | USD |
| CY2012 | us-gaap |
Income Tax Expense Benefit Intraperiod Tax Allocation
IncomeTaxExpenseBenefitIntraperiodTaxAllocation
|
0 | USD |
| CY2013 | us-gaap |
Income Tax Expense Benefit Intraperiod Tax Allocation
IncomeTaxExpenseBenefitIntraperiodTaxAllocation
|
58000 | USD |
| CY2012Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
|
383000 | USD |
| CY2013Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
|
1160000 | USD |
| CY2012Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
11271000 | USD |
| CY2013Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
16409000 | USD |
| CY2012Q4 | us-gaap |
Deferred Tax Assets Other
DeferredTaxAssetsOther
|
193000 | USD |
| CY2013Q4 | us-gaap |
Deferred Tax Assets Other
DeferredTaxAssetsOther
|
418000 | USD |
| CY2012Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
11847000 | USD |
| CY2013Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
17987000 | USD |
| CY2012Q4 | anip |
Deferred Tax Liabilities Depreciation
DeferredTaxLiabilitiesDepreciation
|
236000 | USD |
| CY2013Q4 | anip |
Deferred Tax Liabilities Depreciation
DeferredTaxLiabilitiesDepreciation
|
220000 | USD |
| CY2012Q4 | us-gaap |
Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
|
0 | USD |
| CY2013Q4 | us-gaap |
Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
|
526000 | USD |
| CY2012Q4 | us-gaap |
Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
|
52000 | USD |
| CY2013Q4 | us-gaap |
Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
|
374000 | USD |
| CY2012Q4 | us-gaap |
Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
|
288000 | USD |
| CY2013Q4 | us-gaap |
Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
|
1120000 | USD |
| CY2012Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
11559000 | USD |
| CY2013Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
16867000 | USD |
| CY2012Q4 | us-gaap |
Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
|
0 | USD |
| CY2013Q4 | us-gaap |
Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
|
0 | USD |
| CY2012 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
-0.340 | pure |
| CY2013 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.350 | pure |
| CY2012 | us-gaap |
Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
|
-0.009 | pure |
| CY2013 | us-gaap |
Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
|
0.010 | pure |
| CY2012 | us-gaap |
Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
|
0.177 | pure |
| CY2013 | us-gaap |
Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
|
0.346 | pure |
| CY2012 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
-0.022 | pure |
| CY2013 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
0.550 | pure |
| CY2013 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0 | pure |
| CY2012 | us-gaap |
Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
|
1522000 | USD |
| CY2013 | us-gaap |
Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
|
-414000 | USD |
| CY2011Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
18000 | shares |
| CY2012 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
0 | shares |
| CY2013 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
21000 | shares |
| CY2012 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
|
18000 | shares |
| CY2013 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
|
0 | shares |
| CY2012Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
0 | shares |
| CY2013Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
120000 | shares |
| CY2012Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
0 | shares |
| CY2013Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
99000 | shares |
| CY2012Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
|
0 | shares |
| CY2013Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
|
120000 | shares |
| CY2011Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
11.00 | |
| CY2012 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
0 | |
| CY2013 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
6.36 | |
| CY2012 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
|
11.00 | |
| CY2013 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
|
0 | |
| CY2012Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
0 | |
| CY2013Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
50.35 | |
| CY2012Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
|
0 | |
| CY2013Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
|
59.59 | |
| CY2012Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
|
0 | |
| CY2013Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
|
50.35 | |
| CY2011 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P6Y2M12D | |
| CY2013 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P2Y4M24D | |
| CY2012 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
|
P0Y | |
| CY2013 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
|
P10M24D | |
| CY2012 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
|
P0Y | |
| CY2013 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
|
P2Y4M24D | |
| CY2012Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
0 | USD |
| CY2013Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
81000 | USD |
| CY2012Q4 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
|
0 | USD |
| CY2013Q4 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
|
0 | USD |
| CY2012Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
|
0 | USD |
| CY2013Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
|
81000 | USD |
| CY2012 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
0 | shares |
| CY2013 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
0 | shares |
| CY2012 | anip |
Share Based Compensation Arrangement By Share Based Payment Award Option Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionExercisesInPeriodWeightedAverageExercisePrice
|
0 | |
| CY2013 | anip |
Share Based Compensation Arrangement By Share Based Payment Award Option Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionExercisesInPeriodWeightedAverageExercisePrice
|
0 | |
| CY2013 | anip |
Share Based Compensation Arrangement By Share Based Payment Award Options Assumed In Business Combination Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedInBusinessCombinationWeightedAverageExercisePrice
|
59.59 | |
| CY2013 | anip |
Share Based Compensation Arrangement By Share Based Payment Award Options Assumed In Business Combination
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedInBusinessCombination
|
99000 | shares |
| CY2012 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
|
0 | USD |
| CY2013 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
|
0 | USD |
| CY2013 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
|
P3Y6M11D | |
| CY2012Q3 | anip |
Number Of Institutional Investors To Whom Offering Made
NumberOfInstitutionalInvestorsToWhomOfferingMade
|
1 | pure |
| CY2012Q3 | anip |
Class Of Warrant Or Right Expiration Period
ClassOfWarrantOrRightExpirationPeriod
|
P5Y | |
| CY2013Q4 | us-gaap |
Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
|
686000 | shares |
| CY2013Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
|
996000 | USD |
| CY2013Q4 | us-gaap |
Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
|
5104000 | USD |
| CY2013 | us-gaap |
Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
|
29795000 | USD |
| CY2013 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
36000 | USD |
| CY2013 | us-gaap |
Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
|
433000 | USD |
| CY2013 | us-gaap |
Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
|
809000 | USD |
| CY2013 | us-gaap |
Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
|
0 | USD |
| CY2013 | anip |
Increase Decrease In Accrued Compensation Liabilities
IncreaseDecreaseInAccruedCompensationLiabilities
|
-2854000 | USD |
| CY2012 | anip |
Increase Decrease In Accrued Compensation Liabilities
IncreaseDecreaseInAccruedCompensationLiabilities
|
0 | USD |
| CY2013 | us-gaap |
Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
|
-2260000 | USD |
| CY2012 | us-gaap |
Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
|
0 | USD |
| CY2012Q4 | us-gaap |
Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
|
6124000 | USD |
| CY2011Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-34284000 | USD |
| CY2012 | anip |
Common Stock Issued For Cashless Warrant Exercise At Par
CommonStockIssuedForCashlessWarrantExerciseAtPar
|
0 | USD |
| CY2012 | anip |
Preferred Stock Issued For Cashless Warrant Exercise At Par
PreferredStockIssuedForCashlessWarrantExerciseAtPar
|
-3000 | USD |
| CY2012 | us-gaap |
Dividends Preferred Stock Stock
DividendsPreferredStockStock
|
6922000 | USD |
| CY2012 | anip |
Effect Of Reverse Merger Value
EffectOfReverseMergerValue
|
0 | USD |
| CY2013 | us-gaap |
Dividends Preferred Stock Stock
DividendsPreferredStockStock
|
4975000 | USD |
| CY2013 | anip |
Adjustments To Additional Paid In Capital Non Cash Compensation Relating To Business Combination
AdjustmentsToAdditionalPaidInCapitalNonCashCompensationRelatingToBusinessCombination
|
4418000 | USD |
| CY2013 | anip |
Convertible Preferred Stock Cancelled
ConvertiblePreferredStockCancelled
|
53726000 | USD |
| CY2013 | us-gaap |
Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
|
809000 | USD |
| CY2012 | us-gaap |
Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
|
0 | USD |
| CY2013Q4 | us-gaap |
Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
|
148000 | USD |
| CY2013Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
|
78000 | USD |
| CY2013Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
|
53000 | USD |
| CY2013Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
|
44000 | USD |
| CY2013Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
|
29000 | USD |
| CY2013Q4 | us-gaap |
Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
|
0 | USD |
| CY2013Q4 | us-gaap |
Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
|
352000 | USD |
| CY2013Q4 | anip |
Business Combination Deferred Tax Assets Established Gross
BusinessCombinationDeferredTaxAssetsEstablishedGross
|
9600000 | USD |
| CY2013Q4 | anip |
Business Combination Deferred Tax Liabilities Established Gross
BusinessCombinationDeferredTaxLiabilitiesEstablishedGross
|
3900000 | USD |
| CY2013Q4 | anip |
Business Combination Purchase Price Allocation Deferred Tax Assets Net
BusinessCombinationPurchasePriceAllocationDeferredTaxAssetsNet
|
0 | USD |
| CY2013 | us-gaap |
Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
|
38000 | USD |
| CY2012 | us-gaap |
Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
|
36000 | USD |
| CY2013Q4 | anip |
Charge Backs And Other Accruals As Percent Of Gross Revenue
ChargeBacksAndOtherAccrualsAsPercentOfGrossRevenue
|
0.6 | pure |
| CY2013Q4 | anip |
Business Combination Deferred Tax Asset Liability Valuation Allowance Established
BusinessCombinationDeferredTaxAssetLiabilityValuationAllowanceEstablished
|
-5700000 | USD |
| CY2013Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
|
991000 | USD |
| us-gaap |
Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
|
7100000 | USD | |
| CY2013Q4 | anip |
Business Combination Cost Of Acquired Entity Purchase Price
BusinessCombinationCostOfAcquiredEntityPurchasePrice
|
29800000 | USD |
| CY2012 | us-gaap |
Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
|
900000 | USD |
| CY2013 | us-gaap |
Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
|
6200000 | USD |
| CY2013 | anip |
Acquired Non Cash Net Assets
AcquiredNonCashNetAssets
|
11597000 | USD |
| CY2012 | anip |
Acquired Non Cash Net Assets
AcquiredNonCashNetAssets
|
0 | USD |
